MWNA
AMED

Marshall Wace North America’s Amedisys AMED Stock Holding History

Marshall Wace North America’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-213,359
Closed -$52.3M – 1411
2021
Q2 		$52.3M Sell
213,359
-37,858
-15% -$9.93M 0.22% 97
2021
Q1 		$66.5M Sell
251,217
-25,927
-9% -$7.31M 0.28% 79
2020
Q4 		$81.3M Sell
277,144
-85,318
-24% -$21.9M 0.37% 59
2020
Q3 		$85.7M Sell
362,462
-85,327
-19% -$19.4M 0.55% 36
2020
Q2 		$88.9M Buy
447,789
+247,111
+123% +$46.1M 0.59% 36
2020
Q1 		$36.8M Sell
200,678
-51,648
-20% -$9.19M 0.28% 97
2019
Q4 		$42.1M Sell
252,326
-38,579
-13% -$5.74M 0.2% 136
2019
Q3 		$38.1M Buy
290,905
+211,148
+265% +$27.5M 0.22% 113
2019
Q2 		$9.68M Buy
+79,757
New +$9.47M 0.06% 245
2019
Q1 		– Sell
-1,124
Closed -$132K – 1536
2018
Q4 		$132K Buy
+1,124
New +$132K ﹤0.01% 1034
2018
Q2 		– Sell
-63,652
Closed -$3.84M – 1362
2018
Q1 		$3.84M Sell
63,652
-144,507
-69% -$8.23M 0.02% 626
2017
Q4 		$11M Buy
208,159
+192,916
+1,266% +$10.2M 0.06% 356
2017
Q3 		$854K Sell
15,243
-101,699
-87% -$5.38M 0.01% 982
2017
Q2 		$7.37M Buy
116,942
+11,821
+11% +$688K 0.05% 389
2017
Q1 		$5.36M Buy
+105,121
New +$5.01M 0.04% 382

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marshall Wace North America's AMED Position: Q3 2021 in Review

Marshall Wace North America sold out of Amedisys (AMED) in Q3 2021, closing a stake of 213,359 shares — an estimated $52.3M sold.

Marshall Wace North America first reported a position in AMED in Q1 2017 and held it in 15 quarters. The position peaked at $88.9M in Q2 2020. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Marshall Wace North America reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 213,359 Amedisys shares in Q3 2021, an estimated $52.3M.
  • Marshall Wace North America first reported a position in Amedisys in Q1 2017 and held it in 15 quarters.
  • Marshall Wace North America's Amedisys position peaked at $88.9M in Q2 2020.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.